NASCAR is partnering with Regeneron to educate people on the two most common forms of advanced non-melanoma skin cancer.

New York Gov. Kathy Hochul's skin-cancer removal treatment Friday underscored the importance of preventive screening protecting yourself from the sun. The 66-year-old governor announced a day ...

Biden’s lesion — located on his chest — was removed as part of his comprehensive health assessment, the White House said.The lesion was later biopsied and confirmed to be basal cell carcinoma.

Causes can range from somewhat harmless sun spots and milia to more serious pityriasis alba, vitiligo, and tinea versicolor ...

CHANCES ARE, ONE out of five of you reading this will be diagnosed with skin cancer by the time you hit age 70. As the most ...

Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face. Locally advanced tumors in particular can be difficult to treat surgically. A ...

Hochul, 66, said she is set to have a removal procedure on Friday morning. Basal cell carcinoma is among the most common types of skin cancer. It is highly curable, especially when it is caught early.

NEW YORK-- New York Gov. Kathy Hochul said Thursday she has been diagnosed with skin cancer. Hochul told reporters she is having a procedure to remove it. "My doctor discovered a basal cell ...

Prognosis: Removal typically cures the cancer. Most SCCs are slow-growing, though this type of skin cancer is more likely to grow deeper into the skin and spread. If SCCs spread to other organs, ...

A routine skin care segment on "Good Day Philadelphia" led to host Mike Jerrick's on-air skin cancer diagnosis when dermatologist Dr. Joanna Walker identified basal cell carcinoma on his elbow.

Hochul, 66, said she is set to have a removal procedure on Friday morning. Basal cell carcinoma is among the most common types of skin cancer. It is highly curable, especially when it is caught early.

Ressler, J. M., et al. (2025) Efficacy and tolerability of neoadjuvant therapy with Talimogene laherparepvec in cutaneous basal cell carcinoma: a phase II trial (NeoBCC trial).Nature Cancer.doi ...